Lloyd Price’s Post

HealthTech IPO's in 2025? Omada Health, Hinge Health, Sword Health, Doctolib, Aledade, Quantum Health https://lnkd.in/egpRNZaU The IPO landscape for HealthTech startups in 2025 is likely to be dynamic, influenced by various factors such as market conditions, company performance, and regulatory changes. While it's challenging to predict with certainty which specific companies will go public, the following six HealthTech startups have the potential to be among the IPO candidates: 1) Omada Health: This company specialises in digital health programs for chronic conditions like diabetes and obesity. Its strong track record and focus on a growing market segment make it a potential IPO candidate. 2) Hinge Health: Hinge Health offers digital musculoskeletal care, including physical therapy and pain management. Its innovative approach and growing patient base could position it for an IPO. 3) Sword Health: Sword Health focuses on digital musculoskeletal care and physical therapy. Similar to Hinge Health, its potential for growth and impact on patient outcomes could make it a viable IPO candidate. 4) Doctolib: As a leading European healthcare booking platform, Doctolib has a strong market presence and could be well-positioned for an IPO. 5) Aledade: Aledade is a value-based primary care platform that works with physician groups. Its focus on improving healthcare outcomes and reducing costs could make it an attractive IPO target. 6) Quantum Health: Quantum Health is a healthcare navigation and advocacy company. Its ability to help patients access quality care and reduce healthcare costs could be a selling point for investors. Nelson Advisors work with Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email [email protected]  HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk #HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy #OmadaHealth #HingeHealth #SwordHealth #Doctolib #Aledade #QuantumHealth https://lnkd.in/egpRNZaU

HealthTech IPO's in 2025? Omada Health, Hinge Health, Sword Health, Doctolib, Aledade, Quantum Health https://lnkd.in/egpRNZaU The IPO landscape for HealthTech startups in 2025 is likely to be dynamic, influenced by various factors such as market conditions, company performance, and regulatory changes. While it's challenging to predict with certainty which specific companies will go public, the following six HealthTech startups have the potential to be among the IPO candidates: 1) Omada Health: This company specialises in digital health programs for chronic conditions like diabetes and obesity. Its strong track record and focus on a growing market segment make it a potential IPO candidate. 2) Hinge Health: Hinge Health offers digital musculoskeletal care, including physical therapy and pain management. Its innovative approach and growing patient base could position it for an IPO. 3) Sword Health: Sword Health focuses on digital musculoskeletal care and physical therapy. Similar to Hinge Health, its potential for growth and impact on patient outcomes could make it a viable IPO candidate. 4) Doctolib: As a leading European healthcare booking platform, Doctolib has a strong market presence and could be well-positioned for an IPO. 5) Aledade: Aledade is a value-based primary care platform that works with physician groups. Its focus on improving healthcare outcomes and reducing costs could make it an attractive IPO target. 6) Quantum Health: Quantum Health is a healthcare navigation and advocacy company. Its ability to help patients access quality care and reduce healthcare costs could be a selling point for investors. Nelson Advisors work with Healthcare Technology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email [email protected]  HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk #HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy #HingeHealth #SwordHealth #Doctolib #Aledade #QuantumHealth https://lnkd.in/egpRNZaU

HealthTech IPO's in 2025? Omada Health, Hinge Health, Sword Health, Doctolib, Aledade, Quantum Health https://lnkd.in/egpRNZaU The IPO landscape for HealthTech startups in 2025 is likely to be dynamic, influenced by various factors such as market conditions, company performance, and regulatory changes. While it's challenging to predict with certainty which specific companies will go public, the following six HealthTech startups have the potential to be among the IPO candidates: 1) Omada Health: This company specialises in digital health programs for chronic conditions like diabetes and obesity. Its strong track record and focus on a growing market segment make it a potential IPO candidate. 2) Hinge Health: Hinge Health offers digital musculoskeletal care, including physical therapy and pain management. Its innovative approach and growing patient base could position it for an IPO. 3) Sword Health: Sword Health focuses on digital musculoskeletal care and physical therapy. Similar to Hinge Health, its potential for growth and impact on patient outcomes could make it a viable IPO candidate. 4) Doctolib: As a leading European healthcare booking platform, Doctolib has a strong market presence and could be well-positioned for an IPO. 5) Aledade: Aledade is a value-based primary care platform that works with physician groups. Its focus on improving healthcare outcomes and reducing costs could make it an attractive IPO target. 6) Quantum Health: Quantum Health is a healthcare navigation and advocacy company. Its ability to help patients access quality care and reduce healthcare costs could be a selling point for investors. Nelson Advisors work with Healthcare Technology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email [email protected]  HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk #HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy #OmadaHealth #HingeHealth #SwordHealth #Doctolib #Aledade #QuantumHealth https://lnkd.in/egpRNZaU

HealthTech IPO's in 2025? Omada Health, Hinge Health, Sword Health, Doctolib, Aledade, Quantum Health https://lnkd.in/egpRNZaU The IPO landscape for HealthTech startups in 2025 is likely to be dynamic, influenced by various factors such as market conditions, company performance, and regulatory changes. While it's challenging to predict with certainty which specific companies will go public, the following six HealthTech startups have the potential to be among the IPO candidates: 1) Omada Health: This company specialises in digital health programs for chronic conditions like diabetes and obesity. Its strong track record and focus on a growing market segment make it a potential IPO candidate. 2) Hinge Health: Hinge Health offers digital musculoskeletal care, including physical therapy and pain management. Its innovative approach and growing patient base could position it for an IPO. 3) Sword Health: Sword Health focuses on digital musculoskeletal care and physical therapy. Similar to Hinge Health, its potential for growth and impact on patient outcomes could make it a viable IPO candidate. 4) Doctolib: As a leading European healthcare booking platform, Doctolib has a strong market presence and could be well-positioned for an IPO. 5) Aledade: Aledade is a value-based primary care platform that works with physician groups. Its focus on improving healthcare outcomes and reducing costs could make it an attractive IPO target. 6) Quantum Health: Quantum Health is a healthcare navigation and advocacy company. Its ability to help patients access quality care and reduce healthcare costs could be a selling point for investors. Predicting the exact market conditions for HealthTech IPOs in 2025 is challenging, as it depends on numerous factors. However, based on current trends and historical data, we can make some educated assumptions. Nelson Advisors work with Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email [email protected]  HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb #HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy #OmadaHealth #HingeHealth #SwordHealth #Doctolib #Aledade #QuantumHealth https://lnkd.in/egpRNZaU

Infant gut health and global care are taking centre stage in healthcare innovation! This week's Startup Health Insights reports a $150M investment surge driving transformative change across diverse healthcare sectors. Startups are leading the way with advancements in infant gut health and expanding global care initiatives. Check out the full report here: https://lnkd.in/guRTYy9Y #HealthcareInnovation #StartupHealth #GlobalCare #InfantHealth 🌟👶🏥

Some of the most difficult processes for digital health startups to navigate are those related to reimbursement and coding. It's not uncommon for a startup to launch thinking there is an existing code out there that would work for its product, only to find out that their device wouldn’t qualify for reimbursement using existing codes. To avoid this, it's important to collect data early on and get a head start on creating a new code. #HRX #Startups #Reimbursement

Why Digital Health Startups Should Start Thinking About Their Reimbursement Pathway Earlier Some of the most difficult processes for digital health startups to navigate are those related to reimbursement and coding. Startups will often need to create entirely new codes for their products, so they should start thinking about this sooner rather than later, experts said at a recent conference. https://lnkd.in/gn78MQuS #startups #devices #diagnostics #healthtech #digitalhealth #reimbursement

SteerX congratulates Healthify on its recent USD 20M funding round, led by Khosla Ventures, LeapFrog Investments, and Claypond Capital, the family office of Indian healthcare magnate Dr Ranjan Pai. This strategic investment will fuel Healthify's expansion into the US market and enhance its AI-driven nutrition and fitness coaching capabilities. Founders Tushar Vashisht, Sachin Shenoy, and Matthew Cherian have demonstrated exceptional vision and leadership in revolutionizing personalized health solutions. Vinod Khosla, Founder of Khosla Ventures, states, "With AI, everyone can have a personal nutritionist and health coach to make informed health choices daily. Healthify has proven this in India and is now ready to bring its expertise to the United States." Healthify's growth is a demonstration of the potential in India's HealthTech sector. We wish Healthify continued success in its endeavors. #Healthify #HealthTech #Funding #USExpansion #AI #HealthcareInnovation #SteerX

Digital Health Venture Capital Activity in Q1 2024  - Four main segments: #Telehealth, #Digital #Therapeutics, #Health #Coaching & Wellness, and #Digital #Care #Management.  - Digital health funding remained stable at around $1.1 billion across 77 deals, similar to the previous three quarters.  - This level of activity is significantly lower compared to previous years.  - Top deals included Transcarent's $126.0 million Series D and Rightway's $108.8 million late-stage round.  - Alumni Ventures was the most active digital health VC investor with four deals. • Market Trends:  - There's an ongoing drought in VC exits, with few notable exceptions.  - Consolidation is expected in the digital health space, driven by reimbursement difficulties in digital therapeutics and the rapid growth of GLP-1 drugs.  - IPO activity was limited, with expectations for high-quality startups to potentially wait until 2025 for public offerings. • Notable IPOs  - Waystar, a healthcare IT company, went public at a $3.5 billion valuation.  - Tempus AI raised $410.7 million in its IPO at a $6.1 billion valuation, testing investor appetite for unprofitable healthtech business models. • Care Search Segment:  - Several VC-backed care search startups, including WeDoctor (微医集团), Zocdoc, and Headway • Carrum Health  - Founded in 2014, Carrum Health is a treatment and surgery navigation platform.  - It offers bundled payment solutions for self-insured employers, focusing on procedures in musculoskeletal, cardiac, cancer, and bariatric surgery.  - The company has raised $95.0 million in total funding, with its last valuation at $310.0 million.  - Carrum Health's business model leverages network effects and partnerships with care navigation platforms.